Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zepbound
Pharma
Novo, Lilly obesity meds 'highly cost-effective': ICER report
ICER has high confidence in the drugs' cost-effectiveness but also voiced concerns over the drugs' impact on healthcare budgets.
Eric Sagonowsky
Sep 9, 2025 10:30am
'Sharp rise' in illegal obesity drugs, Europe warns
Sep 5, 2025 11:16am
Wegovy tops Zepbound on CV risk reduction in real-world study
Sep 2, 2025 11:33am
Lilly links up with JD Health for DTC drug sales in China
Aug 29, 2025 10:20am
Texas has sued Eli Lilly over an alleged kickback scheme
Aug 12, 2025 4:26pm
Lilly CEO David Ricks hits back against MFN drug pricing reform
Aug 7, 2025 11:04am
